Stockscreener 앱 받기
12.10
6.98%
0.79
Fibrogen Inc 주식(FGEN)의 최신 뉴스
FibroGen Sells Subsidiary to AstraZeneca for $220 Million - The Globe and Mail
Smart tools for monitoring FibroGen Inc.’s price action2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - Newser
Is FibroGen Inc. exposed to currency risksChart Signals & Consistent Return Investment Signals - خودرو بانک
Is FibroGen Inc. affected by consumer sentimentMarket Growth Report & Short-Term High Return Strategies - خودرو بانک
Using Python tools to backtest FibroGen Inc. strategiesJuly 2025 Rallies & Real-Time Market Trend Scan - Newser
FibroGen completes $220 million sale of Hong Kong subsidiary to AstraZeneca By Investing.com - Investing.com South Africa
FibroGen completes $220 million sale of Hong Kong subsidiary to AstraZeneca - Investing.com India
Using data filters to optimize entry into FibroGen Inc.July 2025 Sector Moves & Daily Volume Surge Signals - Newser
What is FibroGen Inc. s 5 year growth outlookJobs Report & Risk Managed Investment Signals - خودرو بانک
What’s the analyst consensus on FibroGen Inc.Weekly Loss Report & Weekly High Momentum Picks - خودرو بانک
FibroGen Inc. stock outlook for YEARWeekly Profit Analysis & AI Forecasted Stock Moves - Newser
How sentiment analysis helps forecast FibroGen Inc.Bond Market & Community Shared Stock Ideas - Newser
Regression analysis insights on FibroGen Inc. performance2025 Top Decliners & Step-by-Step Swing Trade Plans - Newser
How hedge fund analytics apply to FibroGen Inc. stockJuly 2025 Analyst Calls & Community Trade Idea Sharing Platform - Newser
Idiopathic Pulmonary Fibrosis Diagnostic and Treatment - GlobeNewswire
Idiopathic Pulmonary Fibrosis Diagnostic and Treatment Market Forecasts Report 2025-2030 | Boehringer Ingelheim and FibroGen Lead by Driving Innovations in Pharmacological and Diagnostic Advancements - Yahoo Finance
How does FibroGen Inc. score in quality rankings2025 Technical Patterns & Weekly Stock Performance Updates - خودرو بانک
Using fundamentals and technicals on FibroGen Inc.Portfolio Value Report & Low Risk High Win Rate Stock Picks - Newser
Is a relief rally coming for FibroGen Inc. holdersMarket Growth Report & Long-Term Capital Growth Ideas - Newser
How to build a dashboard for FibroGen Inc. stockMarket Movers & Low Drawdown Momentum Ideas - Newser
FibroGen Sells Subsidiary to AstraZeneca for $220M - MSN
Aug Momentum: What are analysts’ price targets for FibroGen Inc.Inflation Watch & Stepwise Trade Execution Plans - خودرو بانک
Will FibroGen Inc. see short term momentumQuarterly Portfolio Report & Precise Entry and Exit Recommendations - Newser
Will breakout in FibroGen Inc. lead to full recovery2025 Risk Factors & Intraday High Probability Alerts - Newser
Is FibroGen Inc. stock a value trapDip Buying & Low Risk Entry Point Tips - خودرو بانک
Is FibroGen Inc. stock entering bullish territoryEntry Point & AI Forecasted Entry/Exit Points - Newser
Is FibroGen Inc. stock poised for growthQuarterly Market Review & Trade Opportunity Analysis - Newser
Price momentum metrics for FibroGen Inc. explainedQuarterly Investment Review & Weekly Watchlist of Top Performers - Newser
Can machine learning forecast FibroGen Inc. recovery2025 Analyst Calls & Consistent Growth Equity Picks - Newser
FibroGen stock maintains Buy rating at H.C. Wainwright after China sale - Investing.com Nigeria
Volume spikes in FibroGen Inc. stock – what they mean2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser
Using R and stats models for FibroGen Inc. forecastingWeekly Risk Report & Advanced Swing Trade Entry Plans - Newser
Is FibroGen Inc. stock forming a triangle patternJuly 2025 Setups & Verified Trade Idea Suggestions - khodrobank.com
What technical models suggest about FibroGen Inc.’s comebackEntry Point & Smart Investment Allocation Insights - Newser
What are analysts’ price targets for FibroGen Inc.July 2025 Update & Long-Term Safe Investment Ideas - خودرو بانک
Custom strategy builders for tracking FibroGen Inc.Portfolio Risk Summary & AI Powered Market Trend Analysis - Newser
How to use a screener to detect FibroGen Inc. breakoutsWeekly Profit Analysis & Breakout Confirmation Alerts - Newser
1.40%
자본화:
|
볼륨(24시간):